153 related articles for article (PubMed ID: 24740154)
21. Pesticide use modifies the association between genetic variants on chromosome 8q24 and prostate cancer.
Koutros S; Beane Freeman LE; Berndt SI; Andreotti G; Lubin JH; Sandler DP; Hoppin JA; Yu K; Li Q; Burdette LA; Yuenger J; Yeager M; Alavanja MC
Cancer Res; 2010 Nov; 70(22):9224-33. PubMed ID: 20978189
[TBL] [Abstract][Full Text] [Related]
22. Chromosome 8q24 risk variants in hereditary and non-hereditary prostate cancer patients.
Sun J; Lange EM; Isaacs SD; Liu W; Wiley KE; Lange L; Gronberg H; Duggan D; Carpten JD; Walsh PC; Xu J; Chang BL; Isaacs WB; Zheng SL
Prostate; 2008 Apr; 68(5):489-97. PubMed ID: 18213635
[TBL] [Abstract][Full Text] [Related]
23. Prostate cancer genomics, biology, and risk assessment through genome-wide association studies.
Nakagawa H; Akamatsu S; Takata R; Takahashi A; Kubo M; Nakamura Y
Cancer Sci; 2012 Apr; 103(4):607-13. PubMed ID: 22181854
[TBL] [Abstract][Full Text] [Related]
24. Large-scale exploration of gene-gene interactions in prostate cancer using a multistage genome-wide association study.
Ciampa J; Yeager M; Amundadottir L; Jacobs K; Kraft P; Chung C; Wacholder S; Yu K; Wheeler W; Thun MJ; Divers WR; Gapstur S; Albanes D; Virtamo J; Weinstein S; Giovannucci E; Willett WC; Cancel-Tassin G; Cussenot O; Valeri A; Hunter D; Hoover R; Thomas G; Chanock S; Chatterjee N
Cancer Res; 2011 May; 71(9):3287-95. PubMed ID: 21372204
[TBL] [Abstract][Full Text] [Related]
25. Genome scan study of prostate cancer in Arabs: identification of three genomic regions with multiple prostate cancer susceptibility loci in Tunisians.
Shan J; Al-Rumaihi K; Rabah D; Al-Bozom I; Kizhakayil D; Farhat K; Al-Said S; Kfoury H; Dsouza SP; Rowe J; Khalak HG; Jafri S; Aigha II; Chouchane L
J Transl Med; 2013 May; 11():121. PubMed ID: 23668334
[TBL] [Abstract][Full Text] [Related]
26. One thousand genomes imputation in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium aggressive prostate cancer genome-wide association study.
Machiela MJ; Chen C; Liang L; Diver WR; Stevens VL; Tsilidis KK; Haiman CA; Chanock SJ; Hunter DJ; Kraft P;
Prostate; 2013 May; 73(7):677-89. PubMed ID: 23255287
[TBL] [Abstract][Full Text] [Related]
27. Association of prostate cancer risk variants with clinicopathologic characteristics of the disease.
Xu J; Isaacs SD; Sun J; Li G; Wiley KE; Zhu Y; Hsu FC; Wiklund F; Turner AR; Adams TS; Liu W; Trock BJ; Partin AW; Chang B; Walsh PC; Grönberg H; Isaacs W; Zheng S
Clin Cancer Res; 2008 Sep; 14(18):5819-24. PubMed ID: 18794092
[TBL] [Abstract][Full Text] [Related]
28. Genetic prostate cancer risk assessment: common variants in 9 genomic regions are associated with cumulative risk.
Helfand BT; Fought AJ; Loeb S; Meeks JJ; Kan D; Catalona WJ
J Urol; 2010 Aug; 184(2):501-5. PubMed ID: 20620408
[TBL] [Abstract][Full Text] [Related]
29. Genome-wide two-locus interaction analysis identifies multiple epistatic SNP pairs that confer risk of prostate cancer: A cross-population study.
Shen J; Li Z; Song Z; Chen J; Shi Y
Int J Cancer; 2017 May; 140(9):2075-2084. PubMed ID: 28124475
[TBL] [Abstract][Full Text] [Related]
30. Established prostate cancer susceptibility variants are not associated with disease outcome.
Wiklund FE; Adami HO; Zheng SL; Stattin P; Isaacs WB; Grönberg H; Xu J
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1659-62. PubMed ID: 19423541
[TBL] [Abstract][Full Text] [Related]
31. Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.
Eeles RA; Kote-Jarai Z; Al Olama AA; Giles GG; Guy M; Severi G; Muir K; Hopper JL; Henderson BE; Haiman CA; Schleutker J; Hamdy FC; Neal DE; Donovan JL; Stanford JL; Ostrander EA; Ingles SA; John EM; Thibodeau SN; Schaid D; Park JY; Spurdle A; Clements J; Dickinson JL; Maier C; Vogel W; Dörk T; Rebbeck TR; Cooney KA; Cannon-Albright L; Chappuis PO; Hutter P; Zeegers M; Kaneva R; Zhang HW; Lu YJ; Foulkes WD; English DR; Leongamornlert DA; Tymrakiewicz M; Morrison J; Ardern-Jones AT; Hall AL; O'Brien LT; Wilkinson RA; Saunders EJ; Page EC; Sawyer EJ; Edwards SM; Dearnaley DP; Horwich A; Huddart RA; Khoo VS; Parker CC; Van As N; Woodhouse CJ; Thompson A; Christmas T; Ogden C; Cooper CS; Southey MC; Lophatananon A; Liu JF; Kolonel LN; Le Marchand L; Wahlfors T; Tammela TL; Auvinen A; Lewis SJ; Cox A; FitzGerald LM; Koopmeiners JS; Karyadi DM; Kwon EM; Stern MC; Corral R; Joshi AD; Shahabi A; McDonnell SK; Sellers TA; Pow-Sang J; Chambers S; Aitken J; Gardiner RA; Batra J; Kedda MA; Lose F; Polanowski A; Patterson B; Serth J; Meyer A; Luedeke M; Stefflova K; Ray AM; Lange EM; Farnham J; Khan H; Slavov C; Mitkova A; Cao G; ; ; ; Easton DF
Nat Genet; 2009 Oct; 41(10):1116-21. PubMed ID: 19767753
[TBL] [Abstract][Full Text] [Related]
32. Genome-wide association study identifies loci at ATF7IP and KLK2 associated with percentage of circulating free PSA.
Jin G; Zheng SL; Lilja H; Kim ST; Tao S; Gao Z; Young T; Wiklund F; Feng J; Isaacs WB; Rittmaster RS; Gronberg H; Condreay LD; Sun J; Xu J
Neoplasia; 2013 Jan; 15(1):95-101. PubMed ID: 23359319
[TBL] [Abstract][Full Text] [Related]
33. Replication of five prostate cancer loci identified in an Asian population--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3).
Lindström S; Schumacher FR; Campa D; Albanes D; Andriole G; Berndt SI; Bueno-de-Mesquita HB; Chanock SJ; Diver WR; Ganziano JM; Gapstur SM; Giovannucci E; Haiman CA; Henderson B; Hunter DJ; Johansson M; Kolonel LN; Le Marchand L; Ma J; Stampfer M; Stevens VL; Trichopoulos D; Virtamo J; Willett WC; Yeager M; Hsing AW; Kraft P
Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):212-6. PubMed ID: 22056501
[TBL] [Abstract][Full Text] [Related]
34. Chromosome 8q24 markers: risk of early-onset and familial prostate cancer.
Beebe-Dimmer JL; Levin AM; Ray AM; Zuhlke KA; Machiela MJ; Halstead-Nussloch BA; Johnson GR; Cooney KA; Douglas JA
Int J Cancer; 2008 Jun; 122(12):2876-9. PubMed ID: 18360876
[TBL] [Abstract][Full Text] [Related]
35. Association of chromosomal locus 8q24 and risk of prostate cancer: a hospital-based study of German patients treated with brachytherapy.
Meyer A; Schürmann P; Ghahremani M; Kocak E; Brinkhaus MJ; Bremer M; Karstens JH; Hagemann J; Machtens S; Dörk T
Urol Oncol; 2009; 27(4):373-6. PubMed ID: 18625567
[TBL] [Abstract][Full Text] [Related]
36. Manganese superoxide dismutase (MnSOD) genetic polymorphism is associated with risk of early-onset prostate cancer.
Arsova-Sarafinovska Z; Matevska N; Petrovski D; Banev S; Dzikova S; Georgiev V; Sikole A; Sayal A; Aydin A; Suturkova L; Dimovski AJ
Cell Biochem Funct; 2008 Oct; 26(7):771-7. PubMed ID: 18646267
[TBL] [Abstract][Full Text] [Related]
37. Association between genetic variants in the 8q24 cancer risk regions and circulating levels of androgens and sex hormone-binding globulin.
Chu LW; Meyer TE; Li Q; Menashe I; Yu K; Rosenberg PS; Huang WY; Quraishi SM; Kaaks R; Weiss JM; Hayes RB; Chanock SJ; Hsing AW
Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1848-54. PubMed ID: 20551303
[TBL] [Abstract][Full Text] [Related]
38. [Clinical and basic aspects of familial prostate cancer].
Suzuki K; Matsui H; Ohtake N
Gan To Kagaku Ryoho; 2013 Feb; 40(2):159-63. PubMed ID: 23411953
[TBL] [Abstract][Full Text] [Related]
39. Association of prostate cancer risk Loci with disease aggressiveness and prostate cancer-specific mortality.
Pomerantz MM; Werner L; Xie W; Regan MM; Lee GS; Sun T; Evan C; Petrozziello G; Nakabayashi M; Oh WK; Kantoff PW; Freedman ML
Cancer Prev Res (Phila); 2011 May; 4(5):719-28. PubMed ID: 21367958
[TBL] [Abstract][Full Text] [Related]
40. Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study.
Zheng SL; Augustsson-Bälter K; Chang B; Hedelin M; Li L; Adami HO; Bensen J; Li G; Johnasson JE; Turner AR; Adams TS; Meyers DA; Isaacs WB; Xu J; Grönberg H
Cancer Res; 2004 Apr; 64(8):2918-22. PubMed ID: 15087412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
